MoneyWorks4Me · Learning Centre
Learn to invest with confidence
Expert insights on stocks, funds and ETFs from MoneyWorks4Me — grounded, practical, and jargon-free.
Where to begin
Explore the learning hubs
Learn
Basics of Investing
Foundations for new investors — how to start, prepare and think.
Advance Investing
Deeper method, guru lessons and the books worth your time.
Behavioural Investing
Behaviour, psychology and the traps that quietly cost you returns.
Invest in
Stock Investing
Find, value and hold good Indian stocks the MoneyWorks4Me way.
Mutual Funds & ETFs
Choosing funds, building a portfolio and avoiding the usual mistakes.
Plan
Financial Planning
Goals, surplus and the plan your investing should serve.
Portfolio & Planning
Build, manage and rebalance wealth around your financial plan.
Markets & Economy
IPO
IPO and FPO reviews — what the numbers say before you subscribe.
Market Outlook
Where the market stands and what it means for your holdings.
Macros
Rates, inflation, currency and the economy behind the market.
Fresh from the desk
Latest insights
-
October 2020: MoneyWorks4me Outlook
This article covers the following: Review Outlook Risks Indian Economy With Vaccine news stocks have rallied further, will they correct?
-
Gland Pharma IPO Review: Large contract manufacturer for injectables
Gland Pharma IPO Details: Gland Pharma | Market Cap 24,000 Cr CMP 1500 | P/OCF 37x FY21 IPO Date : 9 th November to 11 th November Total shares : 4.32 Cr (For Retail < 2 Lacs – 1.5 Cr)…
-
Understanding the Nifty P/E Ratio: Why Headline Valuations Can Be Misleading
Many investors hesitate to invest when the Nifty’s TTM P/E ratio appears elevated.
-
Is Nifty’s P/E ratio reliable indicator today?
As per historical data, it is observed that investing in equity when the Nifty P/E ratio is high has led to poor returns in the future. Read more!
-
How to save yourself from next Harshad Mehta?
This article covers the following: Was Harshad Mehta kind of Bull Run and Crash the first and last?
-
September 2020: MoneyWorks4me Outlook
This article covers the following: Review Outlook Risks Why should we avoid taking fresh Exposure to US? Is it the right time to add a fresh sum in equity?